SARS-CoV-2 pathogenesis in an angiotensin II–induced heart-on-a-chip disease model and extracellular vesicle screening
Proceedings of the National Academy of Sciences · 09.07.2024 · 121 (28)
DOI: 10.1073/pnas.2403581121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 05.07.2024. Verfasst von Qinghua Wu und 27 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering, University of Toronto, Toronto, ON M5S 3G9, Canada. Hauptthemen laut MEDLINE: Angiotensin II, COVID-19, Induced Pluripotent Stem Cells, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH (NIH), Canadian Government | Canadian Institutes of Health Research (CIHR), Canada Foundation for Innovation/Ontario Research Fund.
Abstract (Originalsprache)
Adverse cardiac outcomes in COVID-19 patients, particularly those with preexisting cardiac disease, motivate the development of human cell-based organ-on-a-chip models to recapitulate cardiac injury and dysfunction and for screening of cardioprotective therapeutics. Here, we developed a heart-on-a-chip model to study the pathogenesis of SARS-CoV-2 in healthy myocardium established from human induced pluripotent stem cell (iPSC)-derived cardiomyocytes and a cardiac dysfunction model, mimicking aspects of preexisting hypertensive disease induced by angiotensin II (Ang II). We recapitulated cytopathic features of SARS-CoV-2-induced cardiac damage, including progressively impaired contractile function and calcium handling, apoptosis, and sarcomere disarray. SARS-CoV-2 presence in Ang II–treated hearts-on-a-chip decreased contractile force with earlier onset of contractile dysfunction and profoundly enhanced inflammatory cytokines compared to SARS-CoV-2 alone. Toward the development of potential therapeutics, we evaluated the cardioprotective effects of extracellular vesicles (EVs) from human iPSC which alleviated the impairment of contractile force, decreased apoptosis, reduced the disruption of sarcomeric proteins, and enhanced beta-oxidation gene expression. Viral load was not affected by either Ang II or EV treatment. We identified MicroRNAs miR-20a-5p and miR-19a-3p as potential mediators of cardioprotective effects of these EVs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Engineering, University of Toronto, Toronto, ON M5S 3G9, Canada.
- Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2C4, Canada.
- Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON M5S 3E5, Canada.
- Department of Pediatrics, Section of Genomic Pediatrics, Medical College of Wisconsin, Milwaukee, WI 53226.
- Department of Medicine, McMaster University, Toronto, ON L8S 4L8, Canada.
- Vaccine and Infectious Disease Organization, Department of Veterinary Microbiology, University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.
ORCID-Profile: Karl T Wagner, Arinjay Banerjee, Trevor R Nash, Chen Yu Li, Uros Kuzmanov, Elizabeth Virlee, Shira Landau, Anthony O Gramolini, Gordana Vunjak-Novakovic, Karen Mossman, Milica Radisic
Förderung
- HHS | NIH (NIH)
- Canadian Government | Canadian Institutes of Health Research (CIHR)
- Canada Foundation for Innovation/Ontario Research Fund
- Natural Sciences and Engineering Research Council of Canada Discovery Grant
- NHLBI NIH HHS
- NSERC Alliance Grant
Zitieren
APA
Wu, Q., Rafatian, N., Wagner, K. T., Blamer, J., Smith, J., Okhovatian, S., Aggarwal, P., Wang, E. Y., Banerjee, A., Zhao, Y., Nash, T. R., Lu, R. X. Z., Portillo-Esquivel, L. E., Li, C. Y., Kuzmanov, U., Mandla, S., Virlee, E., Landau, S., Lai, B. F., …, & Radisic, M. (2024). SARS-CoV-2 pathogenesis in an angiotensin II–induced heart-on-a-chip disease model and extracellular vesicle screening. Proceedings of the National Academy of Sciences, 121(28). https://doi.org/10.1073/pnas.2403581121
Vancouver
Wu Q, Rafatian N, Wagner KT, Blamer J, Smith J, Okhovatian S, et al. SARS-CoV-2 pathogenesis in an angiotensin II–induced heart-on-a-chip disease model and extracellular vesicle screening. Proceedings of the National Academy of Sciences. 2024;121(28). doi:10.1073/pnas.2403581121
BibTeX
@article{Wu2024,
author = {Wu, Qinghua and Rafatian, Naimeh and Wagner, Karl T and Blamer, Jacob and Smith, Jacob and Okhovatian, Sargol and Aggarwal, Praful and Wang, Erika Yan and Banerjee, Arinjay and Zhao, Yimu and Nash, Trevor R and Lu, Rick Xing Ze and Portillo-Esquivel, Luis Eduardo and Li, Chen Yu and Kuzmanov, Uros and Mandla, Serena and Virlee, Elizabeth and Landau, Shira and Lai, Benjamin Fook and Gramolini, Anthony O and Liu, Chuan and Fleischer, Sharon and Veres, Teodor and Vunjak-Novakovic, Gordana and Zhang, Boyang and Mossman, Karen and Broeckel, Ulrich and Radisic, Milica},
title = {SARS-CoV-2 pathogenesis in an angiotensin II–induced heart-on-a-chip disease model and extracellular vesicle screening},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {28},
doi = {10.1073/pnas.2403581121}
}
EUVIMED